Baricitinib vs Montelukast

Baricitinib vs Montelukast: Overview

This comparison examines the pharmacological differences between Baricitinib and Montelukast.

Mechanism of Action

Baricitinib: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

Montelukast: Selective leukotriene D4 receptor antagonist.

Pharmacokinetics

Half-life: Baricitinib — 12 hours; Montelukast — 2.7-5.5 hours.

Chemical Properties

Molecular Formula: Baricitinib — C16H17N7O2S; Montelukast — C35H36ClNO3S.

Molecular Weight: Baricitinib — 371.4170 g/mol; Montelukast — 586.1800 g/mol.

Type: Baricitinib — Small molecule; Montelukast — Small molecule.